IRLAB Therapeutics AB, a company that discovers and develops new treatments for Parkinson’s disease, announced that the company’s annual report for 2022 will be published during the week commencing April 24.
IRLAB Therapeutics AB, a company that discovers and develops new treatments for Parkinson’s disease, announced that the company’s annual report for 2022 will be published during the week commencing April 24.